Loading company…
Malmo-based pharmaceutical company developing oncology products that target specific cancer pathways.
Founded in 2007 by Tommy Andersson and based in Malmo, Sweden, Wntresearch AB, now known as Opsy Holding AB, develops pharmaceutical products for cancer treatment. Its products are marketed to hospitals and oncology specialists, mainly in Sweden and Germany. In April 2012 Global Emerging Markets acquired the firm for SEK 19.5 million, and Pernilla Sandwall is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in